Hand, Foot & Mouth Disease: Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine
by Press Release from Outbreak News Today on (#4J1MJ)
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announced that it has signed an R&D agreement with the Institute of Molecular and Cell Biology (IMCB) in Singapore to develop a fully synthetic vaccine against human viruses that cause Hand, Foot and ["]
The post Hand, Foot & Mouth Disease: Emergex Signs an R&D Agreement with IMCB to Develop a Vaccine appeared first on Outbreak News Today.